Histidine-tryptophan-ketoglutarate (HTK) solution, an intracellular myocardial protective solution originally designed for preserving transplanted donor organs, is increasingly used in China for cardiovascular surgeries requiring prolonged myocardial ischemia, particularly minimally invasive surgery and aortic root surgery. However, there is a lack of expert consensus and guideline literature regarding the ideal safe limit for myocardial protection with a single-dose of HTK solution and the appropriate timing for reperfusion. Given the good myocardial protection observed in clinical practice, HTK solution is gaining favor among surgeons and perfusionists in China, and it is gradually being adopted for cardiovascular procedures involving prolonged arrest times. Our experts will share data from patients who underwent myocardial protection with a single-dose HTK solution during single-center aortic root surgery, which may serve as a basis for the rational application of HTK solution in real-world practice.

We look forward to your participation!

Your Köhler Campus team

About the Event

The Speaker

Registration

This event is targeted at physicians, pharmacists and healthcare professionals and is free of charge.
Register to receive the link to the live webinar using the form below.